Business Type:Trading Company
Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Trading Company
CAS NO.1247119-31-8
Trading information
Product Name | (2R,5R)-1,6-diphenylhexane-2,5-diamine |
CAS No. | 1247119-31-8 |
Appearance | white powder |
Purity | 99.0% |
Package | aluminium foil bag; drum |
Payment Terms | L/C; D/A; D/P; T/T |
Delivery | by air; by ship |
Sample Service
Considering the various needs of buyers, we provide small quantity sample to customers. You are welcomed to contact us for the detailed specifications of our APIs and pharmaceutical intermediates. Customers are also expected to confirm the type of freight transport and payment. Any more question please contact us directly.
Escrow Service
Allyrise accept Escrow Service which is based on Lookchem as a third-party. Both buyer and seller are guranteed that their transaction is simple and secure.
Other Cobicistat Intermediates Provided by Allyrise
(2R,5R)-1,6-diphenylhexane-2,5-diamine is used as a kind of Cobicistat intermediates. Other Cobicistat intermediates are listed below.
(2R,5R)-1,6-diphenylhexane-2,5-diamine (CAS No. : 1247119-31-8)
(S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanoic acid (CAS No. : 1004316-92-0)
thiazol-5-ylmethyl (2R,5R)-5-amino-1,6-diphenylhexan-2-ylcarbamate hydrochloride (CAS No. : 1247119-33-0)
Technical Team
Jiangsu Allyrise Pharmaceutical Co., Ltd have a young and innovative technician team with average age of 29 and backgrounds of famous universerties. We have rich experience in lab research and pilot scale experiment, laying the foundation for further personnel cultivation.
Research and Development
Relying on advanced research platform and relative service of China Medicine City, Allyrise have made achievements in areas of antineoplastic, antiviral, diabetes drugs in recent years, with more than 20 kinds of APIs and advanced intermediates magnified in pilotscale experiment. The products are widely sold to famous pharmaceutical companies from around the world. To enhance our research and development level, Allyrise developed close cooperation with foreign pharmaceutical companies in customer synthesis and developing new drugs.